Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where M.J. Slater is active.

Publication


Featured researches published by M.J. Slater.


Journal of Medicinal Chemistry | 2007

Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate

M.J. Slater; E.M. Amphlett; D.M. Andrews; G. Bravi; George Burton; A.G. Cheasty; John Andrew Corfield; M.R. Ellis; R. Fenwick; S. Fernandes; Rossella Guidetti; David Haigh; C.D. Hartley; P.D. Howes; Deborah Lynette Jackson; Richard L. Jarvest; Victoria Lucy Helen Lovegrove; Katrina Jane Medhurst; Nigel R. Parry; H. Price; P. Shah; O.M.P. Singh; R. Stocker; Pia Thommes; C. Wilkinson; A. Wonacott


Journal of Hepatology | 2007

[594] GSK625433; A NOVEL AND HIGHLY POTENT INHIBITOR OF THE HCV NS5B POLYMERASE

F. Gray; E.M. Amphlett; H. Bright; L. Chambers; A.G. Cheasty; R. Fenwick; David Haigh; D. Hartley; P.D. Howes; Richard L. Jarvest; F. Mirzai; F. Nerozzi; Nigel R. Parry; M.J. Slater; Stephen A. Smith; Pia Thommes; C. Wilkinson; E. Williams


Abstracts Of Papers Of The American Chemical Society | 2007

Identification of GSK625433: A novel clinical candidate for the treatment of hepatitis C.

David Haigh; E.M. Amphlett; G. Bravi; H. Bright; V. Chung; C.L. Chambers; A.G. Cheasty; M.A. Convery; M.R. Ellis; R. Fenwick; D.F. Gray; C.D. Hartley; P.D. Howes; Richard L. Jarvest; Katrina Jane Medhurst; A. Mehbob; D. Mesogiti; F. Mirzai; F. Nerozzi; Nigel R. Parry; N. Roughley; T. Skarzynski; M.J. Slater; Stephen A. Smith; R. Stocker; C.J. Theobald; P.J. Thomas; Pia Thommes; J.H. Thorpe; C. Wilkinson


Archive | 2005

Preparation of N-acyldihydropyrroles as hepatitis C virus (HCV) inhibitors.

David Haigh; M.J. Slater


Archive | 2004

Synthesis of 1-acyl-pyrrolidine derivatives for the treatment of viral infections.

David Haigh; C.D. Hartley; P.D. Howes; Deborah Lynette Jackson; P. Shah; M.J. Slater


Archive | 2004

Preparation of 5-thiazole substituted 2-pyrrolidinecarboxylic acids as antiviral agents for hepatitis C virus

David Haigh; Deborah Lynette Jackson; P. Shah; M.J. Slater


Archive | 2004

Preparation of acylated indoline and tetrahydroquinoline derivatives as hepatitis C virus (HCV) inhibitors.

G. Bravi; Richard Martin Grimes; Rossella Guidetti; David Haigh; C.D. Hartley; Jacqueline Elizabeth Mordaunt; P. Shah; M.J. Slater


Archive | 2004

Preparation of acyl isoindoline derivatives and acyl isoquinoline derivatives as anti-viral agents.

G. Bravi; John Andrew Corfield; David Haigh; Victoria Lucy Helen Lovegrove; P. Shah; M.J. Slater


Archive | 2004

Preparation of cyanothiazolylpyrrolidinecarboxylates and related compounds as antivirals

George Burton; H.S. Goodland; David Haigh; Terry Kiesow; Thomas W. Ku; M.J. Slater


Archive | 2003

Preparation of heteroaryl acyl pyrrolidine derivatives as antiviral agents.

G. Bravi; Rossella Guidetti; David Haigh; C.D. Hartley; P.D. Howes; Deborah Lynette Jackson; Victoria Lucy Helen Lovegrove; P. Shah; M.J. Slater; Katrina Jane GlaxoSmithKl Stevenage Wareing

Collaboration


Dive into the M.J. Slater's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

P.D. Howes

University of California

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

F. Nerozzi

University of California

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge